Photoreceptor degeneration: genetic and mechanistic dissection of a complex trait

The retina provides exquisitely sensitive vision that relies on the integrity of a uniquely vulnerable cell, the photoreceptor (PR). The genetic and mechanistic causes of retinal degeneration due to PR cell death — which occurs in conditions such as retinitis pigmentosa and age-related macular degeneration — are being successfully dissected. Over one hundred loci, some containing common variants but most containing rare variants, are implicated in the genetic architecture of this complex trait. This genetic heterogeneity results in equally diverse disease mechanisms that affect almost every aspect of PR function but converge on a common cell death pathway. Although genetic and mechanistic diversity creates challenges for therapy, some approaches — particularly gene-replacement therapy — are showing considerable promise.

[1]  P. Campochiaro,et al.  Antioxidants slow photoreceptor cell death in mouse models of retinitis pigmentosa , 2007, Journal of cellular physiology.

[2]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[3]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[4]  F. Holz,et al.  Discrete arcs of increased fundus autofluorescence in retinal dystrophies and functional correlate on microperimetry , 2008, Eye.

[5]  A. J. Roman,et al.  Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations. , 2008, Investigative ophthalmology & visual science.

[6]  T. Veen,et al.  Significant photoreceptor rescue by treatment with a combination of antioxidants in an animal model for retinal degeneration , 2007, Neuroscience.

[7]  A. Ciccodicola,et al.  Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa , 2000, Nature Genetics.

[8]  M. Lavail,et al.  Light and inherited retinal degeneration , 2006, British Journal of Ophthalmology.

[9]  R. Iezzi,et al.  Photoreceptor neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide. , 2009, Investigative ophthalmology & visual science.

[10]  A. Bird,et al.  FUNDUS AUTOFLUORESCENCE IMAGING: Review and Perspectives , 2008, Retina.

[11]  Bethan E. Hoskins,et al.  Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. , 2003, American journal of human genetics.

[12]  R. Roepman,et al.  Leber congenital amaurosis: Genes, proteins and disease mechanisms , 2008, Progress in Retinal and Eye Research.

[13]  T. Léveillard,et al.  Identification and characterization of rod-derived cone viability factor , 2004, Nature Genetics.

[14]  Don H. Anderson,et al.  Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration: Characterization, ethnic distribution and evolutionary implications , 2006, Annals of medicine.

[15]  N. Katsanis,et al.  The Vertebrate Primary Cilium in Development, Homeostasis, and Disease , 2009, Cell.

[16]  S. Kim,et al.  Complement activation by bisretinoid constituents of RPE lipofuscin. , 2009, Investigative ophthalmology & visual science.

[17]  B. Charlesworth,et al.  A polygenic basis for late-onset disease. , 2003, Trends in genetics : TIG.

[18]  A Hofman,et al.  Risk factors for age-related macular degeneration: Pooled findings from three continents. , 2001, Ophthalmology.

[19]  J. Stamler,et al.  Redox-based regulation of signal transduction: principles, pitfalls, and promises. , 2008, Free radical biology & medicine.

[20]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[21]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. J. Klevering,et al.  Basal laminar drusen caused by compound heterozygous variants in the CFH gene. , 2008, American journal of human genetics.

[23]  L. Marnett,et al.  Endogenous reactive intermediates as modulators of cell signaling and cell death. , 2006, Chemical research in toxicology.

[24]  H. Omran,et al.  When cilia go bad: cilia defects and ciliopathies , 2008, Nature Reviews Molecular Cell Biology.

[25]  J. Nathans,et al.  ABCR, the ATP-binding Cassette Transporter Responsible for Stargardt Macular Dystrophy, Is an Efficient Target of All-trans-retinal-mediated Photooxidative Damage in Vitro , 2001, The Journal of Biological Chemistry.

[26]  K. Holsinger The neutral theory of molecular evolution , 2004 .

[27]  S. Daiger,et al.  IMP Dehydrogenase Type 1 Associates with Polyribosomes Translating Rhodopsin mRNA* , 2008, Journal of Biological Chemistry.

[28]  D. Heine-Suñer,et al.  An integrated map of the human regulator of complement activation (RCA) gene cluster on 1q32. , 1999, Molecular immunology.

[29]  G. Jensen,et al.  Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. , 2004, Ophthalmology.

[30]  J. Stone,et al.  Mechanisms of photoreceptor death and survival in mammalian retina , 1999, Progress in Retinal and Eye Research.

[31]  C. Cepko,et al.  Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa , 2009, Nature Neuroscience.

[32]  T. Reh,et al.  Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. , 2009, Cell stem cell.

[33]  Eberhart Zrenner,et al.  Photoreceptor Cell Death Mechanisms in Inherited Retinal Degeneration , 2008, Molecular Neurobiology.

[34]  T. Aleman,et al.  Loss of cone photoreceptors caused by chromophore depletion is partially prevented by the artificial chromophore pro-drug, 9-cis-retinyl acetate. , 2009, Human molecular genetics.

[35]  K. Jellinger Recent advances in our understanding of neurodegeneration , 2009, Journal of Neural Transmission.

[36]  G. Travis,et al.  Mechanisms of cell death in the inherited retinal degenerations. , 1998, American journal of human genetics.

[37]  M. Miyagi,et al.  Carboxyethylpyrrole Protein Adducts and Autoantibodies, Biomarkers for Age-related Macular Degeneration* , 2003, Journal of Biological Chemistry.

[38]  E. White,et al.  Metabolic catastrophe as a means to cancer cell death , 2007, Journal of Cell Science.

[39]  B. J. Klevering,et al.  Mutations in the ABCA4 (ABCR) gene are the major cause of autosomal recessive cone-rod dystrophy. , 2000, American journal of human genetics.

[40]  Robert A Linsenmeier,et al.  Retinal oxygenation and oxygen metabolism in Abyssinian cats with a hereditary retinal degeneration. , 2006, Investigative ophthalmology & visual science.

[41]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[42]  V. Sheffield,et al.  A Core Complex of BBS Proteins Cooperates with the GTPase Rab8 to Promote Ciliary Membrane Biogenesis , 2007, Cell.

[43]  N. Avadhani,et al.  Mitochondrial signaling: the retrograde response. , 2004, Molecular cell.

[44]  T. Léveillard,et al.  Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[45]  Joe G Hollyfield,et al.  Oxidative damage–induced inflammation initiates age-related macular degeneration , 2008, Nature Medicine.

[46]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death , 2005, Cell Death and Differentiation.

[47]  T. Léveillard,et al.  [Retinal repair by transplantation of photoreceptor precursors]. , 2007, Medecine sciences : M/S.

[48]  D. Chung,et al.  Recent advances in ocular gene therapy , 2009, Current opinion in ophthalmology.

[49]  B. Jones,et al.  Retinal remodeling triggered by photoreceptor degenerations , 2003, The Journal of comparative neurology.

[50]  Neuron Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little? , 2010 .

[51]  M. Kimura The Neutral Theory of Molecular Evolution: Introduction , 1983 .

[52]  G. Acland,et al.  Age-dependent disease expression determines remodeling of the retinal mosaic in carriers of RPGR exon ORF15 mutations. , 2009, Investigative ophthalmology & visual science.

[53]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J Nathans,et al.  Molecular genetics of human retinal disease. , 1999, Annual review of genetics.

[55]  R. Ali,et al.  Prospects for retinal gene replacement therapy. , 2009, Trends in genetics : TIG.

[56]  David R. Whikehart,et al.  Biochemistry of the Eye , 1994 .

[57]  B. Weber,et al.  Phenotypic variability and long-term follow-up of patients with known and novel PRPH2/RDS gene mutations. , 2009, American journal of ophthalmology.

[58]  M. Leppert,et al.  Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. , 2001, Investigative ophthalmology & visual science.

[59]  G. Gilkeson,et al.  A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.

[60]  W. Jang,et al.  A2E, a component of lipofuscin, is pro‐angiogenic in vivo , 2009, Journal of cellular physiology.

[61]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[62]  H. Ripps Cell death in retinitis pigmentosa: gap junctions and the 'bystander' effect. , 2002, Experimental eye research.

[63]  Adrian Gherman,et al.  The ciliary proteome database: an integrated community resource for the genetic and functional dissection of cilia , 2006, Nature Genetics.

[64]  C. Goodnow,et al.  ENU-mutagenesis: insight into immune function and pathology. , 2006, Current opinion in immunology.

[65]  T. Dryja,et al.  Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. , 1994, Science.

[66]  R. Spaide,et al.  Fundus autofluorescence imaging , 2020, Progress in Retinal and Eye Research.

[67]  M. Quintiliani The oxygen effect in radiation inactivation of DNA and enzymes. , 1986, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[68]  R. Kaufman,et al.  Antioxidants reduce endoplasmic reticulum stress and improve protein secretion , 2008, Proceedings of the National Academy of Sciences.

[69]  A. Bird,et al.  Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence; a review and update , 2007, Documenta Ophthalmologica.

[70]  Tiansen Li,et al.  Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[71]  D. Bok,et al.  Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. , 2005, Investigative ophthalmology & visual science.

[72]  Jane Y. Wu,et al.  Identification of photoreceptor genes affected by PRPF31 mutations associated with autosomal dominant retinitis pigmentosa , 2007, Neurobiology of Disease.

[73]  D. F. Andrews,et al.  A one-hit model of cell death in inherited neuronal degenerations , 2000, Nature.

[74]  R. Mcinnes,et al.  Progress toward understanding the genetic and biochemical mechanisms of inherited photoreceptor degenerations. , 2003, Annual review of neuroscience.

[75]  Peter M. G. Munro,et al.  The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. , 2002, Journal of cell science.

[76]  Anand Swaroop,et al.  Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. , 2009, Annual review of genomics and human genetics.

[77]  A. Mcmahon,et al.  Polyunsaturated very-long-chain C28–C36 fatty acids and retinal physiology , 2009, British Journal of Ophthalmology.

[78]  D. Turnbull,et al.  Do organellar genomes function as long-term redox damage sensors? , 2009, Trends in genetics : TIG.

[79]  P. Sieving,et al.  Preventing blindness in retinal disease: ciliary neurotrophic factor intraocular implants. , 2007, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[80]  W. Hauswirth,et al.  Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme. , 2007, Experimental eye research.

[81]  A. Vingrys,et al.  The contribution of glycolytic and oxidative pathways to retinal photoreceptor function. , 2003, Investigative ophthalmology & visual science.

[82]  U. Wolfrum,et al.  Rhodopsin transport in the membrane of the connecting cilium of mammalian photoreceptor cells. , 2000, Cell motility and the cytoskeleton.

[83]  V. Sheffield,et al.  Missense variations in the fibulin 5 gene and age-related macular degeneration. , 2004, The New England journal of medicine.

[84]  M. Agbaga,et al.  Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids , 2008, Proceedings of the National Academy of Sciences.

[85]  M. Lavail,et al.  Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor , 1990, Nature.

[86]  Colin A. Johnson,et al.  A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies , 2009, Nature Genetics.

[87]  S Berman,et al.  Retinal damage by light in rats. , 1966, Investigative ophthalmology.

[88]  R A Knight,et al.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 , 2005, Cell Death and Differentiation.

[89]  M. Jay On the heredity of retinitis pigmentosa. , 1982, The British journal of ophthalmology.

[90]  Kathleen A. Marshall,et al.  Safety and efficacy of gene transfer for Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[91]  C. Cremers,et al.  Usher syndrome and Leber congenital amaurosis are molecularly linked via a novel isoform of the centrosomal ninein-like protein. , 2009, Human molecular genetics.

[92]  J. Chory,et al.  Coordination of gene expression between organellar and nuclear genomes , 2008, Nature Reviews Genetics.

[93]  R. W. Young Solar radiation and age-related macular degeneration. , 1988, Survey of ophthalmology.

[94]  A. Briscoe,et al.  The spectrum of human rhodopsin disease mutations through the lens of interspecific variation. , 2004, Gene.

[95]  T. Rosenberg,et al.  Identification of novel USH2A mutations: implications for the structure of USH2A protein , 2000, European Journal of Human Genetics.

[96]  Judy H. Cho,et al.  Finding the missing heritability of complex diseases , 2009, Nature.

[97]  A. Hofman,et al.  Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. , 2006, JAMA.

[98]  C. Lumsden,et al.  Scale-free neurodegeneration: cellular heterogeneity and the stretched exponential kinetics of cell death. , 2005, Journal of theoretical biology.

[99]  C. Cremers,et al.  Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. , 2004, American journal of human genetics.

[100]  Nick Tyler,et al.  Effect of gene therapy on visual function in Leber's congenital amaurosis. , 2008, The New England journal of medicine.

[101]  J. Gardiner,et al.  Neurotrophic Support and Oxidative Stress: Converging Effects in the Normal and Diseased Nervous System , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[102]  T. L. McGee,et al.  Search for Recessive Retinitis Pigmentosa Genes Using Microarray Analysis of RNA Expression Levels in Lymphoblasts , 2006 .

[103]  A. J. Lambert,et al.  Low rates of hydrogen peroxide production by isolated heart mitochondria associate with long maximum lifespan in vertebrate homeotherms , 2007, Aging cell.

[104]  B. Jones,et al.  Neural remodeling in retinal degeneration , 2003, Progress in Retinal and Eye Research.

[105]  Kang Zhang,et al.  Genetics of Age-Related Macular Degeneration , 2011 .

[106]  P. Dash,et al.  Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: possible role in spatial memory deficits , 1996, Brain Research.

[107]  B. Kraupp,et al.  In situ detection of fragmented dna (tunel assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note , 1995, Hepatology.

[108]  Zy Li,et al.  Rod photoreceptor neurite sprouting in retinitis pigmentosa , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[109]  J. Nathans,et al.  Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[110]  K. Nakanishi,et al.  A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. , 1999, Investigative ophthalmology & visual science.

[111]  S. Lipton,et al.  Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases , 2007, Cellular and Molecular Life Sciences.

[112]  T. Aleman,et al.  Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[113]  A. V. Cideciyan,et al.  Lifespan and mitochondrial control of neurodegeneration , 2004, Nature Genetics.

[114]  Alexander Sumaroka,et al.  In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[115]  J. Szlyk,et al.  Perceived and actual performance of daily tasks: relationship to visual function tests in individuals with retinitis pigmentosa. , 2001, Ophthalmology.

[116]  P. Campochiaro,et al.  Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[117]  A. Wright,et al.  The human retinitis pigmentosa GTPase regulator gene variant database , 2008, Human mutation.

[118]  Scott W. Cousins,et al.  Implications for Age-Related Macular Degeneration , 2010 .

[119]  M. D'urso,et al.  The ABCA4 2588G>C Stargardt mutation: single origin and increasing frequency from South-West to North-East Europe , 2002, European Journal of Human Genetics.

[120]  K. Palczewski,et al.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. , 2007, Annual review of pharmacology and toxicology.

[121]  R. Masland The fundamental plan of the retina , 2001, Nature Neuroscience.

[122]  Constance L. Cepko,et al.  HDAC4 Regulates Neuronal Survival in Normal and Diseased Retinas , 2009, Science.

[123]  E. Thompson,et al.  Allelic disequilibrium and allele frequency distribution as a function of social and demographic history. , 1997, American journal of human genetics.

[124]  C. Goodnow,et al.  Genome-wide ENU mutagenesis to reveal immune regulators. , 2001, Immunity.

[125]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[126]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[127]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[128]  A. Milam,et al.  Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. , 2003, Experimental eye research.

[129]  J. Kopitz,et al.  Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cells. , 2010, Investigative ophthalmology & visual science.

[130]  P. Humphries,et al.  An experimental platform for systemic drug delivery to the retina , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[131]  Gideon Rechavi,et al.  Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. , 2009, Cell stem cell.

[132]  J. Lupski,et al.  Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4) , 2001, Human Genetics.

[133]  D. Uhrín,et al.  Structural basis for complement factor H–linked age-related macular degeneration , 2007, The Journal of experimental medicine.

[134]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[135]  Edwin M Stone,et al.  Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics , 2008, Proceedings of the National Academy of Sciences.

[136]  M. Cheetham,et al.  Molecular chaperones and photoreceptor function , 2008, Progress in Retinal and Eye Research.

[137]  Bärbel Rohrer,et al.  Multiple, parallel cellular suicide mechanisms participate in photoreceptor cell death. , 2006, Experimental eye research.

[138]  A. Bird,et al.  Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene , 2006, British Journal of Ophthalmology.

[139]  A. Pande,et al.  Novel Lipofuscin Bisretinoids Prominent in Human Retina and in a Model of Recessive Stargardt Disease* , 2009, The Journal of Biological Chemistry.

[140]  P. Sieving,et al.  Assessment of foveal cone photoreceptors in Stargardt's macular dystrophy using a small dot detection task , 1993, Vision Research.

[141]  Y. Sasai,et al.  Stepwise differentiation of pluripotent stem cells into retinal cells , 2009, Nature Protocols.

[142]  P. Sieving,et al.  A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa. , 2002, American journal of human genetics.

[143]  B. Morgan,et al.  The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. , 2009, Human molecular genetics.

[144]  A. Cooper,et al.  Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. , 2004, Molecular cell.

[145]  J. Grunwald,et al.  Retinal hemodynamics in retinitis pigmentosa. , 1996, American journal of ophthalmology.

[146]  D. Hunt,et al.  Expression of PRPF31 mRNA in patients with autosomal dominant retinitis pigmentosa: a molecular clue for incomplete penetrance? , 2003, Investigative ophthalmology & visual science.

[147]  Robert Lanza,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Long-Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration , 2009 .

[148]  Chao Zhang,et al.  IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response , 2007, Science.

[149]  H. Kaplan,et al.  Stem cells as tools in regenerative therapy for retinal degeneration. , 2009, Archives of ophthalmology.

[150]  Robin A. J. Smith,et al.  Targeting antioxidants to mitochondria by conjugation to lipophilic cations. , 2007, Annual review of pharmacology and toxicology.

[151]  J. Sears,et al.  Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration , 2006, Proceedings of the National Academy of Sciences.